BDNF: The Protein Behind Neuroplasticity Claims

BDNF appears in nearly every nootropic marketing page, and the gap between what it does and what products claim about it is wide.

What it does

Brain-derived neurotrophic factor is a protein supporting neuron survival, differentiation and synaptic plasticity. It is implicated in long-term potentiation, the cellular process underlying learning. Reduced BDNF has been associated with depression and with neurodegenerative conditions in observational work, and antidepressant treatment is associated with increased BDNF in some studies.

What raises it

Aerobic exercise has the most consistent evidence, with acute increases in circulating BDNF after exercise reported repeatedly. Learning and environmental enrichment raise it in animal work. Sleep and caloric restriction have been implicated. Some compounds raise it in cell or animal models, which is where most supplement claims originate — and effects in a dish or a mouse do not establish effects in a person taking a fraction of that dose orally.

Where the evidence is stretched

Three problems recur in marketing. First, circulating BDNF measured in blood is an imperfect proxy for brain BDNF. Second, animal and cell findings are cited as though human. Third, raising a biomarker is not the same as producing a clinical benefit — the biomarker is a step in a proposed chain, not the outcome. When a product claims to stimulate BDNF, the questions are whether that was shown in humans, at what dose, and whether any cognitive outcome followed.

A note on Cognicept

We publish this blog on the Cognicept official website, so treat anything we say about our own product as coming from an interested party. Cognicept is a liquid dropper supplement taken daily, and it makes no claim to treat, cure or prevent memory loss, dementia or any other condition. It also has a documented verification problem we cover in our reviews and complaints report.